DexCare

DexCare

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.dexcare.com

Last Round

Series C

Jun 21, 2023

Total Funding Raised

$146M

Company Overview

DexCare is a healthcare technology company that offers an access optimization platform to intelligently manage health system capacity and digital demand, ensuring patients receive timely and appropriate care while enhancing revenue and satisfaction for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Platform-as-a-Service, Telemedicine, Healthcare Analytics, Patient Engagement

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

care orchestrationpatient navigationdigital front doorcapacity optimizationEMR integrationonline appointment schedulingpatient acquisitionhealthcare logisticsload balancingvirtual caretelemedicine platformpatient flow managementEpic integrationhealthcare APIPaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DexCare Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DexCare Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJun 21, 2023
Series BJan 13, 2022
Series AMar 22, 2021

Key People

Founding team and executive leadership

Matthew Blosl

Chief Executive Officer (CEO)

Executive Team

Chris Carruthers

VP Of Product, Chief Innovation Officer, VP Of Solutions

Executive Team

DexCare Investors

Notable investors and investment history

InvestorRounds
Define VenturesSeries C, Series B, Series A
Kaiser Permanente VenturesSeries C, Series A, Series B
Frist Cressey VenturesSeries A, Series B, Series C
ICONIQ GrowthSeries C
Allumia VenturesSeries A, Series B
SpringRock VenturesSeries C, Series A, Series B
Define VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 28, 2026

    Ravi Doddivaripalli joins as the new CTO.

  • Dec 15, 2025

    Rakshay Jain joins as Chief Product Officer.

DexCare Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DexCare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DexCare's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range134
Year Founded2021
Last FundingJun 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.